IBM

Here's What You May Have Missed About International Business Machines (IBM)

Shares of Technology sector company International Business Machines moved 1.0% today, and are now trading at a price of $151.89. The large-cap stock's daily volume was 570,523 compared to its average volume of 3,964,029. The S&P 500 index returned a 0.0% performance.

International Business Machines Corporation, together with its subsidiaries, provides integrated solutions and services worldwide. The company is based in Armonk and has 288,300 full time employees. Its market capitalization is $138,693,640,192. International Business Machines currently offers its equity investors a dividend that yields 4.4% per year.

14 analysts are following International Business Machines and have set target prices ranging from $110.0 to $179.0 per share. On average, they have given the company a rating of buy. At today's prices, IBM is trading 4.18% away from its average analyst target price of $145.79 per share.

Over the last year, IBM's share price has increased by 6.0%, which represents a difference of -9.0% when compared to the S&P 500. The stock's 52 week high is $153.21 per share whereas its 52 week low is $120.55. International Business Machines's average free cash flow over the last 6 years has been $11.77 Billion, but they have been decreasing at an average rate of -1.4%. This may prove a challenge to the long term sustainability of the stock's upwards trend.

Date Reported Cash Flow from Operations ($ k) Capital expenditures ($ k) Free Cash Flow ($ k) YoY Growth (%)
2023 12,278,000 1,390,000 10,888,000 19.79
2022 10,435,000 1,346,000 9,089,000 -15.33
2021 12,796,000 2,062,000 10,734,000 -31.1
2020 18,197,000 2,618,000 15,579,000 24.79
2019 14,770,000 2,286,000 12,484,000 5.33
2018 15,247,000 3,395,000 11,852,000
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS